{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:01:27Z","timestamp":1785297687058,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012957","name":"Friedrich-Schiller-Universit\u00e4t Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Ein 69-j\u00e4hriger Patient mit einer seropositiven erosiven rheumatoiden Arthritis (RA) stellte sich aufgrund einer progredienten Dyspnoe in unserer Klinik vor. Im Rahmen der Diagnostik wurden mittels einer hochaufl\u00f6senden Computertomographie (HRCT) und einer immunologischen bronchoalveol\u00e4ren Lavage Milchglastr\u00fcbungen als auch eine lymphozyt\u00e4re Alveolitis als Folge einer interstitiellen Lungenerkrankung (ILD) bei einer RA nachgewiesen. Unter Ber\u00fccksichtigung der Vortherapien erfolgte die Umstellung der DMARD (\u201edisease-modifying antirheumatic drug\u201c)-Therapie auf Tofacitinib. Die DMARD-Therapie mit Tofacitinib zeigte eine Reduktion der Milchglastr\u00fcbungen mittels auf k\u00fcnstlicher Intelligenz basierender Quantifizierung der pulmonalen hochaufl\u00f6senden Computertomographie um 33\u202f% im Verlauf \u00fcber 6\u00a0Monate, welche mit einer Verbesserung der Dyspnoesymptomatik assoziiert war. Zusammenfassend stellt Tofacitinib eine effektive antiinflammatorische Therapieoption in der Behandlung einer RA-ILD dar.<\/jats:p>","DOI":"10.1007\/s00393-023-01434-2","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T08:02:08Z","timestamp":1697529728000},"page":"495-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ist JAK-Hemmung eine Option in der Behandlung der interstitiellen Lungenerkrankung bei einer rheumatoiden Arthritis?","Is JAK inhibition an option in the treatment of interstitial lung disease in rheumatoid arthritis?"],"prefix":"10.1007","volume":"83","author":[{"given":"Tobias","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Teichgr\u00e4ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Lassen-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Kroegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Renz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Oelzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"G\u00fcttler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pfeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"issue":"3","key":"1434_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","volume":"183","author":"AL Olson","year":"2011","unstructured":"Olson\u00a0AL, Swigris\u00a0JJ, Sprunger\u00a0DB, Fischer\u00a0A, Fernandez-Perez\u00a0ER, Solomon\u00a0J, Murphy\u00a0J, Cohen\u00a0M, Raghu\u00a0G, Brown\u00a0KK (2011) Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 183(3):372\u2013378","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"1434_CR2","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard\u00a0C, Hilberg\u00a0O, Pedersen\u00a0AB, Ulrichsen\u00a0SP, L\u00f8kke\u00a0A, Bendstrup\u00a0E, Ellingsen\u00a0T (2017) A\u00a0population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 76(10):1700\u20131706","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1434_CR3","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1038\/s41598-021-88734-2","volume":"11","author":"E Cano-Jim\u00e9nez","year":"2021","unstructured":"Cano-Jim\u00e9nez\u00a0E, V\u00e1zquez Rodr\u00edguez\u00a0T, Mart\u00edn-Robles\u00a0I, Villegas\u00a0CD, Garc\u00eda\u00a0JJ, Bollo de Miguel\u00a0E, Robles-P\u00e9rez\u00a0A, Ferrer Galv\u00e1n\u00a0M, Mouronte Roibas\u00a0C, Herrera\u00a0LS et al (2021) Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis. Sci Rep 11(1):9184","journal-title":"Sci Rep"},{"issue":"1","key":"1434_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13075-022-02786-x","volume":"24","author":"T Hoffmann","year":"2022","unstructured":"Hoffmann\u00a0T, Oelzner\u00a0P, Franz\u00a0M, Teichgr\u00e4ber\u00a0U, Renz\u00a0D, F\u00f6rster\u00a0M, B\u00f6ttcher\u00a0J, Kroegel\u00a0C, Schulze\u00a0PC, Wolf\u00a0G et\u00a0al (2022) Assessing the diagnostic value of a\u00a0potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases. Arthritis Res Ther 24(1):107","journal-title":"Arthritis Res Ther"},{"key":"1434_CR5","doi-asserted-by":"publisher","first-page":"1101448","DOI":"10.3389\/fmed.2022.1101448","volume":"9","author":"T Hoffmann","year":"2022","unstructured":"Hoffmann\u00a0T, Oelzner\u00a0P, Teichgr\u00e4ber\u00a0U, Franz\u00a0M, Ga\u00dfler\u00a0N, Kroegel\u00a0C, Wolf\u00a0G, Pfeil\u00a0A (2022) Diagnosing lung involvement in inflammatory rheumatic diseases-where do we currently stand? Front Med 9:1101448","journal-title":"Front Med"},{"issue":"3","key":"1434_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1148\/radiology.189.3.8234692","volume":"189","author":"M Remy-Jardin","year":"1993","unstructured":"Remy-Jardin\u00a0M, Giraud\u00a0F, Remy\u00a0J, Copin\u00a0MC, Gosselin\u00a0B, Duhamel\u00a0A (1993) Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology 189(3):693\u2013698","journal-title":"Radiology"},{"issue":"5","key":"1434_CR7","doi-asserted-by":"publisher","first-page":"103056","DOI":"10.1016\/j.autrev.2022.103056","volume":"21","author":"M Akiyama","year":"2022","unstructured":"Akiyama\u00a0M, Kaneko\u00a0Y (2022) Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev 21(5):103056","journal-title":"Autoimmun Rev"},{"issue":"8","key":"1434_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00393-021-01067-3","volume":"80","author":"K Buschulte","year":"2021","unstructured":"Buschulte\u00a0K, Hoffmann-Vold\u00a0AM, Dobrota\u00a0RD, H\u00f6ger\u00a0P, Krause\u00a0A, Kreuter\u00a0M (2021) Treatment of lung fibrosis in systemic rheumatic diseases (new treatment). Z\u00a0Rheumatol 80(8):743\u2013754","journal-title":"Z Rheumatol"},{"issue":"3","key":"1434_CR9","doi-asserted-by":"publisher","first-page":"e233640","DOI":"10.1001\/jamanetworkopen.2023.3640","volume":"6","author":"MC Baker","year":"2023","unstructured":"Baker\u00a0MC, Liu\u00a0Y, Lu\u00a0R, Lin\u00a0J, Melehani\u00a0J, Robinson\u00a0WH (2023) Incidence of interstitial lung disease in patients with rheumatoid arthritis treated with biologic and targeted synthetic disease-modifying antirheumatic drugs. JAMA Netw Open 6(3):e233640","journal-title":"JAMA Netw Open"},{"issue":"11","key":"1434_CR10","first-page":"2071","volume":"40","author":"U Kalyoncu","year":"2022","unstructured":"Kalyoncu\u00a0U, Bilgin\u00a0E, Erden\u00a0A, Sat\u0131\u015f\u00a0H, Tufan\u00a0A, Tekg\u00f6z\u00a0E, Ate\u015f\u00a0A, Co\u015fkun\u00a0BN, Ya\u011f\u0131z\u00a0B, K\u00fc\u00e7\u00fck\u015fahin\u00a0O et al (2022) Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data. Clin Exp Rheumatol 40(11):2071\u20132077","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1434_CR11","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/rheumatology\/keab740","volume":"61","author":"IB McInnes","year":"2022","unstructured":"McInnes\u00a0IB, Szekanecz\u00a0Z, McGonagle\u00a0D, Maksymowych\u00a0WP, Pfeil\u00a0A, Lippe\u00a0R, Song\u00a0IH, Lertratanakul\u00a0A, Sornasse\u00a0T, Biljan\u00a0A et al (2022) A\u00a0review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition. Rheumatology 61(5):1783\u20131794","journal-title":"Rheumatology"},{"issue":"2","key":"1434_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/acr2.11516","volume":"5","author":"T Hoffmann","year":"2023","unstructured":"Hoffmann\u00a0T, Gassler\u00a0N, Teichgr\u00e4ber\u00a0U, Sandhaus\u00a0T, Oelzner\u00a0P, Wolf\u00a0G, Pfeil\u00a0A (2023) Clinical images: severe interstitial lung disease in Sj\u00f6gren disease\u2014what happens in the lungs? Inflammation or fibrosis? ACR Open Rheumatol 5(2):61\u201362","journal-title":"ACR Open Rheumatol"},{"key":"1434_CR13","doi-asserted-by":"publisher","DOI":"10.1055\/a-2017-8971","author":"M Kreuter","year":"2023","unstructured":"Kreuter\u00a0M, Behr\u00a0J, Bonella\u00a0F, Costabel\u00a0U, Gerber\u00a0A, Hamer\u00a0OW, Heussel\u00a0CP, Jonigk\u00a0D, Krause\u00a0A, Koschel\u00a0D et\u00a0al (2023) Consensus guideline on the interdisciplinary diagnosis of interstitial lung diseases. Pneumologie. https:\/\/doi.org\/10.1055\/a-2017-8971","journal-title":"Pneumologie"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-023-01434-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:05:29Z","timestamp":1723561529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-023-01434-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1007\/s00393-023-01434-2","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"7 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Hoffmann, U.\u00a0Teichgr\u00e4ber, B.\u00a0Lassen-Schmidt, C.\u00a0Kroegel, M.\u00a0Kr\u00e4mer, M.\u00a0F\u00f6rster, D.\u00a0Renz, P.\u00a0Oelzner, J.\u00a0B\u00f6ttcher, M.\u00a0Franz, G.\u00a0Wolf, F.\u00a0G\u00fcttler und A.\u00a0Pfeil geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}